• Ranexa 375 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	375 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Menarini International Operations Luxembourg S.A.

• Ranexa 500 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	500 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Menarini International Operations Luxembourg S.A.

• Ranexa 750 mg prolonged-release tablets

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	750 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Menarini International Operations Luxembourg S.A.

• Ranolazine Alter 375 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	375 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Laboratorios Alter S.A.

• Ranolazine Alter 500 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	500 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Laboratorios Alter S.A.

• Ranolazine Alter 750 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	750 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Laboratorios Alter S.A.

• Ranolazine CINFA 500 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	500 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Laboratorios Cinfa S.A.

• Ranolazine CINFA 750 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	750 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Laboratorios Cinfa S.A.

• Ranolazine Cinfa 375 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	375 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Laboratorios Cinfa S.A.

• Ranolazine Krka 375 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	375 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Krka D.D. Novo Mesto

• Ranolazine Krka 500 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	500 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Krka D.D. Novo Mesto

• Ranolazine Krka 750 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	750 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Krka D.D. Novo Mesto

• Ranolazine Normon 375 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	375 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Laboratorios Normon S.A.

• Ranolazine Normon 500 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	500 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Laboratorios Normon S.A.

• Ranolazine Normon 750 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	750 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Laboratorios Normon S.A.

• Ranolazine Pensa 375 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	375 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Towa Pharmaceutical S.A.

• Ranolazine Pensa 500 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	500 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Towa Pharmaceutical S.A.

• Ranolazine Pensa 750 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	750 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Towa Pharmaceutical S.A.

• Ranolazine Stada 375 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	375 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Laboratorio Stada S.L.

• Ranolazine Stada 500 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	500 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Laboratorio Stada S.L.

• Ranolazine Stada 750 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	750 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Laboratorio Stada S.L.

• Ranolazine Teva 375 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	375 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Teva Pharma S.L.U.

• Ranolazine Teva 500 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	500 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Teva Pharma S.L.U.

• Ranolazine Teva 750 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	750 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Teva Pharma S.L.U.

• Ranozek 375 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	375 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Adamed Laboratorios S.L.U.

• Ranozek 500 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	500 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Adamed Laboratorios S.L.U.

• Ranozek 750 mg prolonged-release tablets EFG

  Form: tablets, prolonged-release

  Active substance	Dosage
  RANOLAZINE	750 mg

  ATC: C01E C01EB C01EB18

  Manufacturer: Adamed Laboratorios S.L.U.